Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 1

Cardiovascular manifestations and treatment in Marfan syndrome

Marfan sendromunda kardiyovasküler tutulum ve tedavi

Pages
46–52
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the follow-up of patients after surgery for aortic aneurysm and dissection, serial imaging studies in order to detect a new onset aneurysm or dissection on different sites of the aorta are essential.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Marfan syndrome is a dominantly inherited connective tissue disease characterized by cardiovascular, skeletal and ocular manifestations which was firstly described by Antoine Marfan in 1896.
📊
Key Findings & Data:The underlying disorder is a mutation, which impairs fibrillin synthesis and is associated with the FBN-1 gene on the 15th chromosome.
💡
Conclusion & Impact:In the follow-up of patients after surgery for aortic aneurysm and dissection, serial imaging studies in order to detect a new onset aneurysm or dissection on different sites of the aorta are essential.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Marfan syndrome is a dominantly inherited connective tissue disease characterized by cardiovascular, skeletal and ocular manifestations which was firstly described by Antoine Marfan in 1896. The underlying disorder is a mutation, which impairs fibrillin synthesis and is associated with the FBN-1 gene on the 15th chromosome. Ghent Nosology is used for diagnosis. The progressive dilatation of the proxi-mal aorta leading to dissection and rupture is the typical feature of the disease. Aortic aneurysm and aortic rupture are the lethal complications of the disorder. Increased life expectancy depends on the control and the prevention of the cardiovascular complications. The most frequent cardiovascular manifestation is the mitral valve involvement. The principal pathologic findings on the mitral valve are annular dilatation, fibromyxomatous changes of the leaflets and chordae, elongation and rupture of chordae and deposition of calcium. Prolapsus occurs in 80% of the cases. Elective surgery with optimal timing is associated with increased survival. In the follow-up of patients after surgery for aortic aneurysm and dissection, serial imaging studies in order to detect a new onset aneurysm or dissection on different sites of the aorta are essential.

Özet

İlk kez 1896'da Antoine Marfan tarafından tariflenen Marfan sendromu, kardiyovasküler, iskelet ve oküler anormalliklerle karakterize bağ doku bozukluğu sonucu ortaya çıkan otozomal dominant geçişli bir hastalıktır. Hastalık fibrillin sentezinin bozulmasına yol açan bir mutasyonla ilişkili olup genel olarak 15. kromozomdaki FBN-1 genine bağlanmıştır. Ghent Kriterleri tanıda kullanılmaktadır. Aorta disseksiyonu ve rüptürüne neden olan proksimal aortanın ilerleyen dilatasyonu hastalığın tipik özelliğidir. Aorta anevrizması ve beklenmeyen anevrizma rüptürü, bu sendromun önemini artıran hayatı tehdit edici özelliğidir. Yaşam süresinin uzaması kardiyovasküler patoloji komplikasyonlarının kontrol veya önlenmesine bağlıdır. En sık kardiyovasküler tutulum mitral kapaktadır. Mitral kapaktaki başlıca patolojik bulgular annuler dilatasyon, yaprakçık ve kordalarda fibromiksomatöz değişiklikler, kordaların uzaması, rüptür ve kalsiyum birikimidir. Prolapsus hastaların %80'inde mevcuttur. Uygun zamanlama ile elektif koşullarda yapılan cerrahinin yaşam süresine olumlu katkısı vardır. Disseksiyon ve anevrizma nedeniyle cerrahi girişimde bulunulan hastaların takibinde aortanın farklı bölgelerinden gelişebilecek anevrizma ve disseksiyonun tespit edilebilmesi için düzenli aralıklarla yapılacak görüntüleme çalışmaları önemlidir.

🔖

Cite This Article

POLAT, A., KIRALİ, K., ERENTUĞ, V., AKINCI, E., YAKUT, C. (2022). Cardiovascular manifestations and treatment in Marfan syndrome. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 1, 46–52. https://ajindex.com/articles/437435

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Galla JD, Griepp RB. Surgical management of aortic and cardiac manifestations of Marfan syndrome. In:Franco KL, Verrier ED editors. Advanced Therapy in Cardiac Surgery. 1st ed. London: B.C. Decker; 1999. p.270-9
  2. Doty JR, Cameron DE. Surgery for Marfan syndrome. In: Franco KL, Verrier ED, editors. Advanced Therapy In Cardiac Surgery. 2nd ed. London: B.C. Decker Inc; 2003. p.304-11
  3. Treasure T. Cardiovascular surgery for Marfan syndrome. Heart 2000;84:674-8
  4. Baumgartner WA, Cameron DE, Redmond M, et al. Operative management of Marfan syndrome: the Johns Hopkins experience. Ann Thorac Surg 1999; 67: 1859-60
  5. Milewicz DM, Michael K, Fisher N et al. Fibrillin-1 (FBN-1) mutations in patients with thoracic aortic aneurysms. Circulation 1996; 94: 2708-11
  6. Dean JCS. Management of Marfan syndrome. Heart 2002; 88: 97-103
  7. Ramirez F, Pereira L. Mutations of extracellular matrix components in vascular disease. Ann Thorac Surg 1999; 67: 1857-8
  8. Allen KJG, Cochran RP, Reinhall PG, Kunzelman KS. Mechanisms of aortic valve incompetence: finite-element modeling of Marfan syndrome. J Thorac Cardiovasc Surg 2001; 122: 946-54
  9. Ergin MA. Baumgartner WA, Kouchoukos NT, Ramirez F, Westaby S. Marfan syndrome. Ann Thorac Surg 1999; 67: 1868-70. 10.Bozbuga N, Erentug V, Kırali K et al. Surgical management of mitral regurgitation in patients with Marfan syndrome.J Heart Valve Dis 2003;12:717-21
  10. Matsuyama S, Ootaki M, Iwata Y, et al. Left midcardiac border of frontal chest radiographs of patients with annulo-aortic ectasia. Radiat Med. 1997; 15: 367-73
  11. Bozbuğa NU, Erentuğ V, Şişmanoğlu, et al. Cardiovascular manifestations in Marfan syndrome during childhood: A case report with ascending aortic aneurysm. Med Bull İstanbul 2003; 36: 20-4
  12. Groenink M, Rozendaal L, Naeff MSJ, et al. Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart 1998; 80: 163-9
  13. Del Rio M, Liotta D. Anatomic and functional aspects of the aorta. In: Liotta D, Del Rio M, Cooley DA, Cabrol C, Griepp RB, Bonser RS, Kato M, editors. Diseases of the Aorta. 1st ed. Buenos Aires: Domingo Liotta Foundation Medical; 2001. pp.1-22
  14. Rozendaal L, Groenink M, Naeff MSJ, et al. Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart 1998; 79: 69-72
  15. Coselli JS, LeMaire SA, Buket S. Marfan syndrome: the variability and outcome of oper